Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Kroger’s AI shopping assistant has ads at launch
Kroger has made advertising part of its AI shopping assistant, following the implementation of advertising features on competitors’ chatbots.
OpenAI brings product carousels to ChatGPT ads
It builds on OpenAI’s product feed campaigns, bringing a Google Shopping-style carousel format to ChatGPT ahead of the Q4 holiday period.
Digiday+ Research: The 2026 guide to holiday marketing strategies, including A-Frame Brands, Mastercard and Ritual
Shoppers continue to grapple with higher prices and affordability, while brands face rising operating costs and increased pressure to prove their marketing dollars are delivering measurable returns.